These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32722421)

  • 1. Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology.
    Lizarralde-Iragorri MA; Shet AS
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis for the prothrombotic state in sickle cell disease.
    Shet AS; Lizarralde-Iragorri MA; Naik RP
    Haematologica; 2020 Oct; 105(10):2368-2379. PubMed ID: 33054077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming challenges of venous thromboembolism in sickle cell disease treatment.
    Ogunsile FJ; Naik R; Lanzkron S
    Expert Rev Hematol; 2019 Mar; 12(3):173-182. PubMed ID: 30773073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
    Faes C; Ilich A; Sotiaux A; Sparkenbaugh EM; Henderson MW; Buczek L; Beckman JD; Ellsworth P; Noubouossie DF; Bhoopat L; Piegore M; Renoux C; Bergmeier W; Park Y; Ataga KI; Cooley B; Wolberg AS; Key NS; Pawlinski R
    Blood; 2019 Jun; 133(23):2529-2541. PubMed ID: 30952675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle Cell Disease and Thromboembolism: New Insights on the Pathophysiology, Diagnosis, and Treatment.
    Dobie G
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic abnormalities in sickle cell disease.
    Lim MY; Ataga KI; Key NS
    Curr Opin Hematol; 2013 Sep; 20(5):472-7. PubMed ID: 23817169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of venous thrombosis.
    Myers DD
    Phlebology; 2015 Mar; 30(1 Suppl):7-13. PubMed ID: 25729062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in understanding the molecular mechanisms of venous thrombosis.
    Preston RJS; O'Sullivan JM; O'Donnell JS
    Br J Haematol; 2019 Jul; 186(1):13-23. PubMed ID: 30906986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of venous thromboembolism.
    Becattini C; Agnelli G
    Curr Opin Pulm Med; 2002 Sep; 8(5):360-4. PubMed ID: 12172436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
    Naik RP; Streiff MB; Lanzkron S
    J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep venous thrombosis.
    López JA; Kearon C; Lee AY
    Hematology Am Soc Hematol Educ Program; 2004; ():439-56. PubMed ID: 15561697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of blood rheology in sickle cell disease.
    Connes P; Alexy T; Detterich J; Romana M; Hardy-Dessources MD; Ballas SK
    Blood Rev; 2016 Mar; 30(2):111-8. PubMed ID: 26341565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
    Sparkenbaugh EM; Henderson MW; Miller-Awe M; Abrams C; Ilich A; Trebak F; Ramadas N; Vital S; Bohinc D; Bane KL; Chen C; Patel M; Wallisch M; Renné T; Gruber A; Cooley B; Gailani D; Kasztan M; Vercellotti GM; Belcher JD; Gavins FE; Stavrou EX; Key NS; Pawlinski R
    Blood; 2023 Apr; 141(15):1871-1883. PubMed ID: 36706361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap.
    Davila J; O'Brien SH; Mitchell WB; Manwani D
    Br J Haematol; 2024 Jun; 204(6):2184-2193. PubMed ID: 38578212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercoagulability in sickle cell disease: new approaches to an old problem.
    Ataga KI; Key NS
    Hematology Am Soc Hematol Educ Program; 2007; ():91-6. PubMed ID: 18024615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulability in sickle cell disease: a curious paradox.
    Ataga KI; Orringer EP
    Am J Med; 2003 Dec; 115(9):721-8. PubMed ID: 14693325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the coagulation system in the pathogenesis of sickle cell disease.
    Nasimuzzaman M; Malik P
    Blood Adv; 2019 Oct; 3(20):3170-3180. PubMed ID: 31648337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review.
    Raslan IA; Solh Z; Kuo KHM; Abdulrehman J
    Hemoglobin; 2024 Jul; 48(4):231-243. PubMed ID: 39420740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.